Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily ...

Clinical hold lifted for late stage cadisegliatin program for diabetesCATT1 Phase 3 trial in patients with type 1 diabetes (T1D) expected to ...

Diabetes is a metabolic disorder caused by dysfunction in the pancreas, the organ responsible for regulating blood sugar levels. Within the pancreas, islet cells secrete insulin to lower blood sugar.

According to a new study published in the journal Biomedicine & Pharmacotherapy, CBD oil may help counteract the negative effects of a high-calorie diet by influencing insulin and glucagon regulation ...

Researchers found significant improvements in insulin sensitivity and pancreatic function in overweight adults who consumed mango daily in a new study from the Illinois Institute of Technology.

Jet lag is one of the worst parts of long-distance traveling or shift work—it makes us tired and cranky, and also plays havoc with our metabolism (and therefore our weight). Now, new research on mice ...

Diabetes management and weight-loss drug Mounjaro has been launched in India by makers Eli Lilly, following approval from the ...

Discover how to get Mounjaro for weight loss, its benefits, side effects, pricing, and how Mitolyn can enhance your results.

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.